As of 10:30 AM on the 3rd, Access Bio is trading at 33,200 KRW, up 11.78% from the previous day. This represents a 169.92% increase compared to August 5. Access Bio is known as a specialized manufacturer of in vitro diagnostic products, including malaria diagnostic kits.

Over the past five days, individual investors have net sold 30 shares, while foreigners and institutions have net sold 1,895 shares and 321 shares, respectively.


On August 24, Access Bio was a market topic with the headline "Two consecutive trading days of sharp decline... from 60,000 KRW level down to 20,000 KRW."



※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing